{ }
001122334455554433221100
001122334455554433221100

immunocore sees institutional investment growth amid mixed analyst ratings

Janus Henderson Group PLC increased its stake in Immunocore to 257,080 shares valued at $16.7 million, while BNP PARIBAS ASSET MANAGEMENT raised its holdings by 16.2% to 397,463 shares worth $13.5 million. Institutional investors own 84.5% of the stock. UBS Group initiated coverage with a "sell" rating and a $24 price target, indicating a potential downside, while other analysts maintain a "Moderate Buy" rating with a consensus target price of $75.17. Immunocore reported a revenue increase of 26.2% year-over-year, with a quarterly earnings per share of ($0.23), surpassing expectations.
13:50 24.10.2024

global fund giants compete for billions in indian bond etfs

Major ETF providers, including BlackRock and Amundi, are competing for a share of the anticipated $5 billion to $10 billion influx into Indian bonds, following JPMorgan's inclusion of Indian debt in its emerging-market index. This move is expected to significantly boost investment in the sector.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.